Assessing Mobile Apps for Adult ADHD

Attention Deficit Hyperactivity Disorder Clinical Trial

Official title: A Randomized, Controlled, Parallel-Group, Intervention Study to Assess At-Home, Digital Therapy for Treating Adult Participants Ages 18-50 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)

Status Recruiting

Clinical Trial Summary

The purpose of this clinical trial is to evaluate the effects of mobile app digital therapies on cognitive function and symptoms in adults diagnosed with ADHD.

Clinical Trial Description

The study is a randomized, parallel group, controlled trial of two mobile app digital therapies. The study will consist of initial screening tests and diagnostics to determine eligibility, followed by outcome measure testing and treatment. On Day 0, the Baseline visit will occur wherein the pre-treatment (baseline) assessments will be conducted on-site. The Treatment period (Day 1 to Day 49) will involve using the digital therapy at home. Midpoint (Day 25) assessments will be conducted on-site to assess key outcomes. Final Post-Treatment (Day 50) assessments will be conducted on-site to assess key outcomes. ;

Related Conditions & MeSH terms

• Attention Deficit Disorder with Hyperactivity
• Attention Deficit Hyperactivity Disorder
• Hyperkinesis

• NCT number: NCT06256003
• Study type: Interventional
• Source: Think Now Incorporated
• Contact: Kristen Emanuel, MS
• Phone: 310-205-1200
• Email: KEnriquez@mednet.UCLA.edu
• Status: Recruiting
• Phase: N/A
• Start date: January 3, 2024
• Completion date: October 2024